Typhoid Antibody Testing Market Share

  • Report ID: 4164
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Typhoid Antibody Testing Market Regional Analysis:

APAC Market Insights 

 Asia Pacific industry is predicted to account for largest revenue share of 41% by 2035, driven by increase in typhoid cases in the region.This is backed by the increase in typhoid cases in developing countries such as India, China, Bangladesh, Nepal, Vietnam, and Laos. These countries report more than 75% of typhoid cases around the world.

Moreover, various government-led initiatives aiming at managing the number of cases and spreading awareness and preventive measures are some factors that are expected to enhance the market growth in this region. For instance, in 2019, more than 450,000 typhoid cases have been found in Bangladesh, of which about 7,400 cases resulted in death.

European Market Statistics  Insights 

The typhoid antibody testing market in Europe is poised to hold a significant market share of 29% by the end of 2035, owing to a highly developed healthcare infrastructure that includes fabulous levels of hygiene and sanitization facilities. They have proper personal hygiene products and public hygiene facilities, along with proper drinking water and food, owing to which a very low number of typhoid cases could be seen in this region. As per World Health Organization, Europe accounts for less than 500 cases of typhoid every year.

Typhoid Antibody Testing Market Overview

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of typhoid antibody testing is assessed at USD 9.04 billion.

The global typhoid antibody testing market size was valued at over USD 8.42 billion in 2025 and is expected to expand at a CAGR of around 8.2%, surpassing USD 18.52 billion revenue by 2035.

Asia Pacific typhoid antibody testing market will hold around 41% share by 2035, driven by increasing typhoid cases and government-led awareness initiatives.

Key players in the market include IDL Biotech AB, LINEAR CHEMICALS, S.L.U, Medical Innovation Ventures Sdn Bhd, Thermo Fisher Scientific, Nectar Lifesciences Ltd., DIALAB GmbH., BIOSYSTEMS S.A., Siemens Healthcare GmbH, NanoEnTek, CerTest Biotec S.L.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos